Breaking News Instant updates and real-time market news.

NVDA

Nvidia

$166.22

3.685 (2.27%)

, PYPL

PayPal

$98.92

1.4 (1.44%)

09:55
03/13/19
03/13
09:55
03/13/19
09:55

Early notable gainers among liquid option names on March 13th

Notable gainers among liquid option names this morning include NVIDIA (NVDA) $166.61 +4.08, PayPal (PYPL) $99.84 +2.32, CVS Health (CVS) $55.93 +1.27, Carnival (CCL) $56.53 +1.28, and Signet Jewelers (SIG) $27.17 +0.60.

NVDA

Nvidia

$166.22

3.685 (2.27%)

PYPL

PayPal

$98.92

1.4 (1.44%)

CVS

CVS Health

$55.60

0.94 (1.72%)

CCL

Carnival

$56.41

1.16 (2.10%)

SIG

Signet Jewelers

$27.10

0.52 (1.96%)

  • 19

    Mar

  • 19

    Mar

  • 03

    Apr

NVDA Nvidia
$166.22

3.685 (2.27%)

03/12/19
MKMP
03/12/19
NO CHANGE
Target $170
MKMP
Neutral
Nvidia's Mellanox deal represents 'strategic addition', says MKM Partners
MKM Partners analyst Ruben Roy kept his Neutral rating and $170 price target on Nvidia (NVDA), saying its proposed $6.9B deal for Mellanox (MLNX) represents a "strategic addition" to its data center portfolio. Given the "complementary and vertically integrated nature of the products", the analyst believes that the regulatory review period should not be rigorous while the earnings accretion from the deal "appears compelling". Despite the positive implication of the deal, Roy maintains a neutral view on Nvidia and believes that its near-term trends remain challenging because of its "significant exposure to the gaming end market" and a slowdown in crypto-related demand.
03/12/19
DADA
03/12/19
DOWNGRADE
Target $128
DADA
Neutral
Mellanox downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Mark Kelleher downgraded Mellanox (MLNX) to Neutral with an unchanged price target of $128 after its announced acquisition by Nvida (NVDA) at $125 per share, saying that he does not anticipate a higher bid to emerge after both of the companies' boards approved the transaction. Kelleher states that if other purchasers such as Intel (INTC) were interested, offers could have been made over the past few months of acquisition speculation.
03/12/19
RHCO
03/12/19
NO CHANGE
Target $210
RHCO
Buy
Nvidia price target raised to $210 from $195 at SunTrust
SunTrust analyst William Stein raised his price target on Nvidia (NVDA) to $210 and kept his Buy rating after its announced acquisition of Melanox (MLNX), saying that while the deal is "defensive" because of its timing during a period of weak demand, it also fits the "strategic and financial" needs. The analyst contends that Nvidia would have been more threatened if Intel (INTC) or Xilinx (XLNX) purchased Melanox, adding that his assumed valuation multiple reflects the company's "structural growth" even though its stock is trading at a discount to its growth tech peers.
03/12/19
LEHM
03/12/19
DOWNGRADE
Target $125
LEHM
Equal Weight
Mellanox downgraded to Equal Weight from Overweight at Barclays
Barclays analystTavy Rosner downgraded Mellanox Technologies (MLNX) to Equal Weight from Overweight following the acquisition by Nvidia (NVDA). The analyst raised his price target for the shares to $125 from $108.
PYPL PayPal
$98.92

1.4 (1.44%)

03/05/19
NOMU
03/05/19
NO CHANGE
Target $105
NOMU
Buy
Downloads of Square's Cash App accelerating, says Nomura Instinet
Nomura Instinet analyst Dan Dolev lowered his price target for Square (SQ) to $105 from $110 while keeping a Buy rating on the shares. The analyst's Cash App versus PayPal's (PYPL) Venmo payments app tracker points to a "healthy pace" of downloads in February with 2.1M additional downloads, and year-over-year download growth accelerating for the second consecutive month to 37%. With 15M active users in December, the number of active Cash App users has more than doubled year-over-year, resulting in a slight improvement to the ratio of active versus total downloads, Dolev tells investors in a research note.
02/28/19
NOMU
02/28/19
NO CHANGE
Target $110
NOMU
Buy
PayPal price target raised to $110 from $100 at Nomura Instinet
Nomura Instinet analyst Bill Carcache raised his price target for PayPal to $110 saying the company's core operating trends "remain healthy." Decelerating growth has emerged as the "PayPal 2.0" bear case, with PayPal catching four downgrades since reporting earnings last quarter, Carcache tells investors in a research note. The analyst says that while he would not minimize the significance of deceleration, he sees "clear evidence" that the headwinds PayPal is facing are transitory. He keeps a Buy rating on the shares.
02/25/19
02/25/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Imax (IMAX) downgraded to Hold from Buy Canaccord by analyst Aravinda Galappatthige, who cited weak box office trends, particularly in China. He believes the uncertainty around the China outlook and the less friendly slate of movies for 2019 will also be headwinds. 2. SQM (SQM) downgraded to Hold from Buy at Deutsche Bank by analyst Chris Terry, who said he is moving to the sidelines following the 9% share price increase over the past two weeks. He likes the fundamentals of the business but believes that the first half of the year "could still provide some moderate headwinds." 3. PayPal (PYPL) downgraded to Neutral from Buy at Buckingham. 4. Motif Bio (MTFB) downgraded to Neutral from Buy at H.C. Wainwright by analyst Raghuram Selvaraju, who said he is unsure whether the FDA would ever approve iclaprim, "regardless of what data Motif might be able to furnish." Further, he believes there is "considerable uncertainty regarding Motif's ability to fund such studies." 5. Allegion (ALLE) downgraded to In-Line from Outperform at Imperial Capital by analyst Jeff Kessler, who sees 7% potential upside following the company's Q4 results and 2019 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/25/19
02/25/19
DOWNGRADE

Neutral
PayPal downgraded to Neutral on valuation, headwinds at Buckingham
As previously reported, Buckingham downgraded PayPal to Neutral from Buy. Analyst Chris Brendler changed his view citing balanced risk/reward and maintained a $99 price target. Brendler sees several near-term headwinds including decelerating core growth rates, continued rate pressure, and underestimated eBay (EBAY) exposure.
CVS CVS Health
$55.60

0.94 (1.72%)

03/12/19
BERN
03/12/19
INITIATION
Target $76
BERN
Outperform
CVS Health initiated with an Outperform at Bernstein
Bernstein initiated CVS Health with an Outperform and $76 price target.
03/06/19
SBSH
03/06/19
NO CHANGE
Target $68
SBSH
Buy
CVS Health price target lowered to $68 from $94 at Citi
Citi analyst Ralph Giacobbe lowered his price target for CVS Health to $68 from $94 but keeps a Buy rating on the shares. The analyst says that while headwinds within the company's retail are significant, he's most surprised with the sizable drop implied within the healthcare benefits segment. However, he sees "a bridge" that gives credence to mid-single digit underlying growth. While admitting it is difficult to gain visibility on 2020, Giacobbe sees a "reasonable path" to $7.20 in earnings per share for 2020.
03/04/19
BARD
03/04/19
NO CHANGE
BARD
Baird investigation finds Ohio, like many buyers, paying too much for drugs
In a research note titled "Major Confusion: Does This Pass Your Sniff Test?," Baird analyst Eric Coldwell details the interplay between Cardinal Health's (CAH) generic marketing company Major Pharmaceuticals and CVS Health (CVS) in Ohio. In Major's catalog is Omeprazole, a generic version of Prilosec, which is available without a subscription. CVS Caremark, which had majority share of pharmacy benefit management services in Ohio, didn't use Maximum Allowable Cost for the product, which led to the state of Ohio paying $6.74 per tablet, or 19 times the amount somebody without a subscription can buy it, Coldwell tells investors in a research note, citing his own investigation. Meanwhile, over the course of five quarters in Ohio, Major's volume market share went from less than 2% to nearly 60% while dollar market share went from 12% to 95%, adds the analyst. He asks, "How does this happen?" The state of Ohio, "like so many other buyers, feels like it is paying too much for drugs," concludes Coldwell.
03/13/19
03/13/19
INITIATION
Target $76

Outperform
Bernstein bullish on CVS Health, initiates coverage with an Outperform
As previously reported, Bernstein analyst Lance Wilkes started coverage of CVS Health with an Outperform rating and $76 price target. The analyst believes the current stock price does not reflect Aetna's solid MCO business and the long-term value of a care delivery strategy at retail. Further, he thinks the current valuation already reflects potential shock to PBM margins and future deterioration in the retail business.
CCL Carnival
$56.41

1.16 (2.10%)

03/13/19
GSCO
03/13/19
UPGRADE
Target $65
GSCO
Buy
Carnival upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Stephen Grambling upgraded Carnival to Buy from Neutral and raised his price target for the shares to $65 from $63. Ramping capacity should drive the company's fundamentals, Grambling tells investors in a research note.
02/06/19
STFL
02/06/19
NO CHANGE
Target $37
STFL
Buy
SeaWorld appointment of new CEO removes a significant overhang, says Stifel
After SeaWorld (SEAS) announced it has appointed Gustavo Antorcha, previously the COO of Carnival Cruise Lines (CCL), as its new CEO, Stifel analyst Steven Wieczynski said he welcome the news, as he believes it removes a significant long-term overhang. However, he also suspect the announcement could have a modestly negative short-term implication for the stock, as he believes some shorter-term focused investors believed the delays in naming a permanent CEO were a sign of leadership actively shopping the company. Although Wieczynski thinks lingering uncertainty over the potential impact of the Zhonghong lock-up expiration in May could remain a near-term overhang, he sees considerable long-term upside for patient shareholders and maintains a Buy rating and $37 price target on SeaWorld shares.
03/13/19
03/13/19
UPGRADE
Target $65

Buy
Carnival raised to Buy at Goldman Sachs on rising unit growth, conservative FY19
As previously reported, Goldman Sachs analyst Stephen Grambling upgraded Carnival to Buy from Neutral and raised his price target for the shares to $65 from $63. The analyst cites the company accelerating its net unit growth from 2.5% in the last 3 years to 5% over the next 3 years and also believes that concerns about net yields in Europe are overblown. Grambling further notes that Carnival's outlook for overall net yields is conservative as it is "well-below" the 5-year average and provides a "lower hurdle for beats and raises throughout 2019." Moreover, the analyst sees valuation on the shares as compelling at 11.4-times expected next-twelve-month earnings.
03/06/19
MSCO
03/06/19
NO CHANGE
Target $54
MSCO
Equal Weight
Morgan Stanley cautious on Carnival ahead of Q1 report
Morgan Stanley analyst Jamie Rollo said the firm's qualitative survey of U.S. travel agents was somewhat more downbeat than last month while quantitative web research was mixed for Carnival (CCL) and positive for Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH). Rollo, who noted he has had a cautious view of the cruise industry for some time due to the significant amount of new capacity coming on-line, added that he is cautious on Carnival ahead of its quarterly report due in late March, stating that he sees limited room for an upgrade to its FY19 yield guidance given weakness at its European brands. He maintains Equal Weight ratings on Carnival and Royal Caribbean and an Overweight rating on Norwegian shares.
SIG Signet Jewelers
$27.10

0.52 (1.96%)

01/18/19
SBSH
01/18/19
DOWNGRADE
SBSH
Sell
Signet Jewelers downgraded to Sell from Neutral at Citi
Citi analyst Paul Lejuez downgraded Signet Jewelers to Sell.
01/18/19
NOMU
01/18/19
NO CHANGE
Target $26
NOMU
Neutral
Signet Jewelers price target lowered to $26 from $42 at Nomura Instinet
Nomura Instinet analyst Simeon Siegel lowered his price target for Signet Jewelers to $26 citing the company's "disappointing" holiday update. The analyst remains "wary of ongoing uncertainties across the business into next year" and keeps a Neutral rating on the shares.
01/18/19
SBSH
01/18/19
DOWNGRADE
Target $20
SBSH
Sell
Citi sees further downside in Signet Jewelers, downgrades to Sell
Citi analyst Paul Lejuez downgraded Signet Jewelers to Sell from Neutral and cut his price target for the shares to $20 from $41. In what was one of the strongest years from the consumer since the recession, Signet's comps and margins have been under pressure, Lejuez tells investors in a research note. The analyst now believes Signet's earnings power is "even lower than we originally thought and what's currently being priced in." Further, Signet is one of the stocks most vulnerable in an economic slowdown, adds Lejuez. He sees further share downside despite yesterday's pullback.
01/18/19
01/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Signet Jewelers (SIG) downgraded to Sell from Neutral at Citi with analyst Paul Lejuez saying in what was one of the strongest years from the consumer since the recession, Signet's comps and margins have been under pressure. 2. Casa Systems (CASA) downgraded to Equal Weight from Overweight at Morgan Stanley and to Hold from Buy at Stifel. 3. Sandy Spring Bancorp (SASR) downgraded to Hold from Buy at Sandler O'Neill and to Market Perform from Outperform at Keefe Bruyette. 4. Interpublic Group (IPG) downgraded to Sector Perform from Outperform at RBC Capital with analyst Steven Cahall saying he expects the company's organic growth to decelerate in 2019 after "recent account losses," stating that after a "fantastic" organic growth rate of 4.6%, Interpublic Group is now facing tougher comps. 5. Nautilus (NLS) downgraded to Neutral from Buy at Sidoti, DA Davidson, and B. Riley FBR, as well as to Hold from Buy at Lake Street. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

21:25
03/25/19
03/25
21:25
03/25/19
21:25
General news
Fed's Rosengren warned that U.S. Q1 growth is likely to be weak »

Fed's Rosengren…

BBBY

Bed Bath & Beyond

$13.87

0.17 (1.24%)

20:44
03/25/19
03/25
20:44
03/25/19
20:44
Periodicals
Activist firms seek to replace Bed Bath & Beyond board, CEO, WSJ says »

Activist funds -Legion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

RTN

Raytheon

$180.58

-0.82 (-0.45%)

, BA

Boeing

$370.52

8.37 (2.31%)

20:36
03/25/19
03/25
20:36
03/25/19
20:36
Hot Stocks
Raytheon kill vehicle hits ICBM target in first dual-salvo test »

For the first time, the…

RTN

Raytheon

$180.58

-0.82 (-0.45%)

BA

Boeing

$370.52

8.37 (2.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

20:35
03/25/19
03/25
20:35
03/25/19
20:35
General news
The "Summary of Opinions" from the BoJ's March meeting »

The "Summary of…

WHD

Cactus

$36.03

1.225 (3.52%)

20:27
03/25/19
03/25
20:27
03/25/19
20:27
Hot Stocks
Cactus VP of Operations sells 229K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$56.67

-0.065 (-0.11%)

, MKC

McCormick

$143.88

1.58 (1.11%)

20:25
03/25/19
03/25
20:25
03/25/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CCL

Carnival

$56.67

-0.065 (-0.11%)

MKC

McCormick

$143.88

1.58 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 26

    Mar

  • 27

    Mar

CRTO

Criteo

$21.99

-3.4 (-13.39%)

20:19
03/25/19
03/25
20:19
03/25/19
20:19
Downgrade
Criteo rating change at KeyBanc »

Criteo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

$0.00

(0.00%)

20:02
03/25/19
03/25
20:02
03/25/19
20:02
Periodicals
Samsung sees weaker environment for display, memory in Q1, Bloomberg says »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$370.52

8.37 (2.31%)

19:51
03/25/19
03/25
19:51
03/25/19
19:51
Hot Stocks
U.S. MDA and Boeing Complete Historic Missile Defense Test »

The U.S. Missile Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

MCD

McDonald's

$185.66

-1.11 (-0.59%)

19:49
03/25/19
03/25
19:49
03/25/19
19:49
Periodicals
McDonald's purchase price of Dynamic Yield above $300M, Bloomberg says »

The purchase of Dynamic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 28

    May

SSNLF

Samsung

$0.00

(0.00%)

19:32
03/25/19
03/25
19:32
03/25/19
19:32
Periodicals
Breaking Periodicals news story on Samsung »

Samsung sees Q1 below…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWR

American States Water

$71.51

0.505 (0.71%)

19:22
03/25/19
03/25
19:22
03/25/19
19:22
Hot Stocks
American States Water CEO sells 12.4K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$56.35

-1.38 (-2.39%)

19:10
03/25/19
03/25
19:10
03/25/19
19:10
Hot Stocks
Methanex confirms receipt of director nominees notice from M&G »

Methanex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BECN

Beacon Roofing

$34.14

0.81 (2.43%)

, SAEX

SAExploration

$4.03

0.13 (3.33%)

18:55
03/25/19
03/25
18:55
03/25/19
18:55
Hot Stocks
Fly Intel: After Hours Movers »

DOWN AFTER EARNINGS:…

BECN

Beacon Roofing

$34.14

0.81 (2.43%)

SAEX

SAExploration

$4.03

0.13 (3.33%)

IQ

iQIYI

$24.01

-0.86 (-3.46%)

MYOK

MyoKardia

$51.87

-2.44 (-4.49%)

CTMX

CytomX Therapeutics

$10.76

0.33 (3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 26

    Mar

  • 21

    May

  • 27

    Mar

HPQ

HP Inc.

$18.97

-0.4 (-2.07%)

18:48
03/25/19
03/25
18:48
03/25/19
18:48
Periodicals
HP lawyer tells court Autonomy's Lynch inflated sales data, Reuters says »

A lawyer for HP told a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

PEGA

Pegasystems

$63.61

-0.27 (-0.42%)

18:45
03/25/19
03/25
18:45
03/25/19
18:45
Hot Stocks
Pegasystems CEO: We are massively changing our marketing strategy »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

SMTC

Semtech

$52.59

-0.38 (-0.72%)

18:32
03/25/19
03/25
18:32
03/25/19
18:32
Hot Stocks
Semtech CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

TMO

Thermo Fisher

$268.89

5.015 (1.90%)

18:24
03/25/19
03/25
18:24
03/25/19
18:24
Hot Stocks
Thermo Fisher CEO: We have a very disciplined M&A process »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

18:24
03/25/19
03/25
18:24
03/25/19
18:24
Periodicals
Parliament forces votes on Brexit plan options, Bloomberg reports »

Lawmakers of U.K.…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.99

-0.56 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$185.66

-1.11 (-0.59%)

18:23
03/25/19
03/25
18:23
03/25/19
18:23
Hot Stocks
McDonald's to acquire Dynamic Yield, terms not stated »

McDonald's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 28

    May

BA

Boeing

$370.52

8.37 (2.31%)

18:22
03/25/19
03/25
18:22
03/25/19
18:22
Periodicals
Boeing software fix to prevent repeated activiation of MCAS, Reuters says »

A Boeing software repair…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ACHC

Acadia

$29.47

-0.59 (-1.96%)

17:58
03/25/19
03/25
17:58
03/25/19
17:58
Hot Stocks
Acadia says President Brett Turner leaving by mutual agreement »

Brent Turner, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$188.78

-2.33 (-1.22%)

17:41
03/25/19
03/25
17:41
03/25/19
17:41
Recommendations
Apple analyst commentary at Piper Jaffray »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

ZFGN

Zafgen

$2.70

-0.15 (-5.26%)

17:38
03/25/19
03/25
17:38
03/25/19
17:38
Hot Stocks
Armistice Capital reports 5.6% passive stake in Zafgen »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$268.56

0.27 (0.10%)

17:36
03/25/19
03/25
17:36
03/25/19
17:36
Hot Stocks
Northrop Grumman awarded $245.05M Navy contract modification »

Northrop Grumman has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.